Revolution Medicines Inc logo

RVMD

Revolution Medicines Inc

$45.14

Earnings Summary

Revenue
$0Mn
Net Profits
$-116Mn
Net Profit Margins
-Inf%

Highlights

Revenue:

Revolution Medicines Inc’s revenue fell -100% since last year same period to $0Mn in the Q1 2024. On a quarterly growth basis, Revolution Medicines Inc has generated -100% fall in its revenue since last 3-months.

Net Profits:

Revolution Medicines Inc’s net profit fell -98.28% since last year same period to $-116Mn in the Q1 2024. On a quarterly growth basis, Revolution Medicines Inc has generated 28.19% jump in its net profits since last 3-months.

Net Profit Margins:

Revolution Medicines Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q1 2024. On a quarterly growth basis, Revolution Medicines Inc has generated -Inf% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Revolution Medicines Inc post its latest quarter earnings

EPS Estimate Current Year
-0.75

Highlights

EPS Estimate Current Year:

Revolution Medicines Inc’s earning per share (EPS) estimates for the current year stand at -0.75.

Key Ratios

Key ratios of the Revolution Medicines Inc post its Q1 2024 earnings

Earning Per Share (EPS)
-0.7
Return on Assets (ROA)
-0.22
Return on Equity (ROE)
-0.36

Highlights

Earning Per Share (EPS):

Revolution Medicines Inc’s earning per share (EPS) jumped 2.78% since last year same period to -0.7 in the Q1 2024. This indicates that the Revolution Medicines Inc has generated 2.78% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Revolution Medicines Inc’s return on assets (ROA) stands at -0.22.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Revolution Medicines Inc’s return on equity (ROE) stands at -0.36.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-08
-0.75
-0.7
6.67%